L-Sepiapterin and CDDO-Me effectively restored this pathway, with CDDO-Me showing greater efficacy in suppressing PEA-15 and reactivating AKT, highlighting their potential to counteract infection-induced metabolic dysfunction. The gene discussed is AKT1; the disease is infection.